Intelligence Profile
Clinical Applications
Testosterone propionate is primarily investigated for hormone replacement therapy in hypogonadal men and select applications in women. The available evidence covers several clinical areas, though research remains limited in some applications.
Hypogonadism in Men
Clinical trials demonstrate testosterone propionate's use in treating male hypogonadism (low testosterone). A completed Phase 3 study (NCT01816295) evaluated testosterone formulations for men with low testosterone, measuring effects on testosterone levels, libido, and energy. Another Phase 3 trial (NCT03242590) focused on dosing validation for oral testosterone undecanoate, providing evidence for testosterone therapy protocols in hypogonadal men.
Women's Health Applications
Several trials explore testosterone propionate use in women, though evidence is more limited:
Breast Cancer Prevention: An ongoing Phase 2 trial (NCT00080756) investigates deslorelin combined with low-dose estradiol and testosterone in premenopausal women at high risk for breast cancer. This approach aims to suppress ovarian function while providing hormone replacement.
Genitourinary Conditions: Two trials examine vaginal testosterone applications. A suspended Phase 1/2 study (NCT01122342) investigated vaginal testosterone cream for atrophic vaginitis in women taking aromatase inhibitors for breast cancer treatment. A currently recruiting Phase 4 trial (NCT04807894) evaluates vaginal testosterone versus placebo for preventing recurrent urinary tract infections.
Research Applications
Preclinical research suggests potential applications in pain management, with one study examining testosterone's role in pain-related empathetic behaviors in mice. Animal studies also investigate testosterone propionate delivery systems, including sustained-release implants for veterinary applications.
Evidence Limitations
While clinical trials demonstrate testosterone propionate's established use in male hypogonadism, evidence for women's health applications remains investigational. Some trials are suspended or have limited enrollment, indicating ongoing uncertainty about optimal dosing and safety profiles in these populations.
This information is for educational purposes only and should not replace consultation with healthcare providers for individual medical decisions.